Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and…

Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and…
What they do: High-throughput organ-on-chip platform + AI image/multi-omics analysis for preclinical drug discovery
Founded: 2022
HQ: Boston area (500 Rutherford Ave, Boston, MA)
Employees: 27
Recent financing: Reported CNY 200M (~$46M) Series A (lead: China Life Private Equity Investment)
Preclinical drug discovery — improving biological relevance and throughput of in vitro disease models to reduce reliance on animal testing.
2022
Biotechnology Research
CNY 200,000,000 (~$46,000,000)
Reported Series A round; multiple sources list a CNY 200M raise (~$46M)
“Has institutional backing including China Life Private Equity Investment, Legend Capital, Tiantu Capital, TriApex, XtalPi, Yael Capital Management Limited, Zhengxuan Investment”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,800+
New This Week
| Company |
|---|